Preclinical immunotherapy with Cytokine-Induced Killer lymphocytes against epithelial ovarian cancer

Despite improvements in surgery and medical treatments, epithelial ovarian cancer (EOC) remains the most lethal gynaecological malignancy. Aim of this study is to investigate the preclinical immunotherapy activity of cytokine-induced killer lymphocytes (CIK) against epithelial ovarian cancers, focus...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Sci Rep
Autors principals: Capellero, S., Erriquez, J., Melano, C., Mesiano, G., Genta, S., Pisacane, A., Mittica, G., Ghisoni, E., Olivero, M., Di Renzo, M. F., Aglietta, M., Sangiolo, D., Valabrega, G.
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group UK 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7160190/
https://ncbi.nlm.nih.gov/pubmed/32296104
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-020-63634-z
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars